Document is current
Any future updates will be listed below
-
Authors
Kerry-Barnard, Sarah
Huntington, Susie https://orcid.org/0000-0002-2854-7441
Fleming, Charlotte
Reid, Fiona
Sadiq, S. Tariq
Drennan, Vari M.
Adams, Elisabeth
Oakeshott, Pippa
-
Funding
Funding for this research was provided by:
Research for Patient Benefit Programme (PB-PG-1014-35007)
- License Information
-
More Information
Article History
Received: 5 November 2019
Accepted: 28 February 2020
First Online: 16 April 2020
Ethics approval and consent to participate
: The study was approved by Bromley Research Ethics Committee (REC), part of the UK Health Departments’ Research Ethics Service, reference 15/LO/1929. Students provided written informed consent.
: N/A
: All authors have completed the Unified Competing Interest Form. PO is a member of the NIHR South London Collaboration for Leadership in Applied Health Research and a member of the esti2 consortium funded under the UKCRC Translational Infection Research Initiative supported by the Medical Research Council (Grant Number G0901608) with contributions from the Biotechnology and Biological Sciences Research Council, the National Institute for Health Research. EA and SH are employed by Aquarius Population Health that receives grants and other funding to work on projects relating to STIs from Cepheid, Binx Health, and St George’s, University of London. STS directs The Applied Diagnostic Research and Evaluation Unit, which has conducted diagnostic evaluations for rapid STI tests for a number of companies including Cepheid, Binx Health, Alere, TwistDx and SpeedDx.
